Status:
COMPLETED
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
Lead Sponsor:
AstraZeneca
Conditions:
Hyperlipidemias
Eligibility:
All Genders
20+ years
Brief Summary
The primary objective is to survey the efficacy of various commercially available statins (a class of lipid-lowering agents, for example, rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastat...
Eligibility Criteria
Inclusion
- patients diagnosed with hyperlipidemia
- Patients who are just starting a statin treatment, who need to switch from current therapy to a statin medication, or who are receiving dosage adjustment of statin as judged by the physicians
- Patients who are willing to participate in this study and who sign an informed consent form
Exclusion
- Pregnancy or breast feeding
- Patient are illiterate or unable to fill the questionnaire for any reason
- Patients with contraindications to the use of certain statins as needed prescribed by physicians (as per commercially available statins package insert) including the use of rosuvastatin.
- Any clinical condition which, in the opinion of the attending physician, would not allow safe administration of the study medications
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
3270 Patients enrolled
Trial Details
Trial ID
NCT00726362
Start Date
December 1 2007
End Date
November 1 2009
Last Update
December 3 2010
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Changhua, Taiwan
2
Research Site
Douliu, Taiwan
3
Research Site
Hualien City, Taiwan
4
Research Site
Kaohsiung City, Taiwan